Context Therapeutics (CNTX) Financials: Revenue & Earnings

CNTX price $0.22 -0.01 -5.92%

Ticker
CNTX
Price
$0.22
Change
-0.01 -5.92%
Market cap ?
$20.29M
P/E ?
-0.50
Dividend yield ?
0.00%
Beta ?
1.72
Sector
Healthcare
Industry
Biotechnology

Financials

2019202020212022202320242025
0000000

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6…

Fair value

CNTX fair value $3.91. Price $0.22. Price is 94% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare CNTX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-0.09——
2026-08-05-0.15-0.09——
2026-05-06-0.09-0.12——
2026-03-19-0.14-0.11—-1.46M
2025-11-05-0.10-0.09——
2025-08-06-0.09-0.06——
2025-05-07-0.05-0.05——
2025-03-20-0.04-0.05——
2024-11-06-0.22-0.11——
2024-08-07-0.04-0.08——
2024-05-08-0.23-0.38——
2024-03-21-0.42-0.3518.95K—
2023-11-09-0.37-0.30——
2023-08-09-0.31-0.20——
2023-05-10-0.40-0.19——
2023-03-22-0.22-0.30——
2022-11-09-0.24-0.25——
2022-08-11-0.25-0.25——
2022-05-11-0.22-0.24——
2022-03-23-0.58-0.27——
2021-12-02-4.00———
2021-06-30-0.73———
2021-03-31-0.09———
2020-12-31-0.08———
2020-09-30-0.09———
2020-06-3021.47———
2020-03-310.08———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-24Pasternak AndyBuy45.00K$0.5825.92K
2026-06-24Stacey Jennifer EvansBuy45.00K$0.5825.92K
2026-06-24West LindaBuy45.00K$0.5825.92K
2026-06-24Smith Karen L.Buy45.00K$0.5825.92K
2026-06-24Walker Luke NathanielBuy45.00K$0.5825.92K
2026-06-24Kantoff Philip W.Buy45.00K$0.5825.92K
2026-02-19Levit Alex C.Buy270.00K$2.32626.40K
2026-02-19Minai-Azary Jennifer LynnBuy275.00K$2.32638.00K
2026-02-19Chagin Karen DeborahBuy290.00K$2.32672.80K
2026-02-19Lehr Martin A.Buy815.00K$2.321.89M
2025-06-12Pasternak AndyBuy138.90K$0.6590.70K
2025-06-12Kantoff Philip W.Buy123.50K$0.6580.65K
2025-06-12Smith Karen L.Buy123.50K$0.6580.65K
2025-06-12Stacey Jennifer EvansBuy123.50K$0.6580.65K
2025-06-12Walker Luke NathanielBuy123.50K$0.6580.65K
2025-06-12West LindaBuy123.50K$0.6580.65K
2025-06-09Lehr Martin A.Buy100.00K$0.7070.08K
2025-06-09Chagin Karen DeborahBuy153.00K$0.70107.56K
2025-06-09Chagin Karen DeborahOther0——
2025-06-06Levit Alex C.Buy20.00K$0.5811.52K
2025-06-06Minai-Azary Jennifer LynnBuy40.01K$0.6425.49K
2025-02-13Minai-Azary Jennifer LynnBuy371.80K$0.81301.16K
2025-02-13Levit Alex C.Buy349.90K$0.81283.42K
2025-02-13Dansky Ullmann ClaudioBuy174.96K$0.81141.72K
2025-02-13Lehr Martin A.Buy802.70K$0.81650.19K
2025-01-13Pasternak AndyBuy20.68K$1.0321.31K
2025-01-13Pasternak AndyOther0——
2024-09-04Smith Karen L.Buy19.32K$2.4346.94K
2024-09-04Smith Karen L.Other0——
2024-09-04Walker Luke NathanielBuy19.32K$2.4346.94K
2024-09-04Walker Luke NathanielOther0——
2024-08-01Dansky Ullmann ClaudioBuy202.17K$2.23450.84K
2024-08-01Dansky Ullmann ClaudioOther0——
2024-06-13Stacey Jennifer EvansBuy25.00K$1.9749.25K
2024-06-13Kantoff Philip W.Buy25.00K$1.9749.25K
2024-06-13West LindaBuy25.00K$1.9749.25K
2024-06-13BERMAN RICHARD JBuy50.00K$1.9798.50K
2024-03-21Minai-Azary Jennifer LynnBuy160.12K$1.07171.32K
2024-03-21Levit Alex C.Buy153.51K$1.07164.26K
2024-03-21Lehr Martin A.Buy291.40K$1.07311.80K
2023-05-31Kantoff Philip W.Buy25.00K$0.8721.75K
2023-05-31West LindaBuy25.00K$0.8721.75K
2023-05-31Stacey Jennifer EvansBuy25.00K$0.8721.75K
2023-05-31BERMAN RICHARD JBuy50.00K$0.8743.50K
2023-02-21Lehr Martin A.Buy5.82K$0.844.90K
2023-02-13Levit Alex C.Buy151.50K$0.84127.37K
2023-02-13Lehr Martin A.Buy287.54K$0.84241.74K
2023-02-13Minai-Azary Jennifer LynnBuy158.00K$0.84132.83K
2023-02-13Lehr Martin A.Buy5.61K$0.874.90K
2023-02-06Lehr Martin A.Buy5.04K$0.974.90K
2023-01-30Lehr Martin A.Buy7.03K$0.704.90K
2023-01-23Lehr Martin A.Buy6.84K$0.724.90K
2023-01-17Lehr Martin A.Buy6.78K$0.745.00K
2022-12-16Minai-Azary Jennifer LynnBuy25.00K$0.7418.50K
2022-12-16Lehr Martin A.Buy20.00K$0.7414.80K
2022-12-09Levit Alex C.Buy6.00K$0.855.09K
2022-08-19Lehr Martin A.Buy13.00K$1.8524.06K
2022-08-17Minai-Azary Jennifer LynnBuy15.00K$1.8027.00K
2022-08-16Sahmoud TarekBuy10.00K$1.9519.50K
2022-08-12Sahmoud TarekBuy25.00K——
2022-06-02West LindaBuy25.00K$2.1954.75K
2022-06-02West LindaBuy25.00K——
2022-06-02Kantoff Philip W.Buy25.00K——
2022-06-02BERMAN RICHARD JBuy50.00K$2.19109.50K
2022-06-02BERMAN RICHARD JBuy50.00K——
2022-06-02Stacey Jennifer EvansBuy25.00K$2.1954.75K
2022-06-02Stacey Jennifer EvansBuy25.00K——
2022-02-25Levit Alex C.Buy107.87K$1.79193.09K
2022-02-25Minai-Azary Jennifer LynnBuy112.47K$1.79201.32K
2022-02-25Lehr Martin A.Buy254.30K$1.79455.20K
2022-02-15Dick Evan G.Buy29.22K$2.0559.91K
2022-02-15Rencher William F.Buy8.00K$2.0516.40K
2021-12-16Lehr Martin A.Buy13.00K$3.2241.85K
2021-11-01Minai-Azary Jennifer LynnBuy52.75K$5.59294.89K
2021-11-01Minai-Azary Jennifer LynnOther0——
2021-10-22Lehr Martin A.Buy10.00K$5.0050.00K
2021-10-22Lehr Martin A.Buy586.48K——
2021-10-22Lehr Martin A.Buy210.72K——
2021-10-22Lehr Martin A.Sell210.72K——
2021-10-22Lehr Martin A.Sell586.48K——
2021-10-22Lehr Martin A.Buy52.68K$7.14376.14K
2021-10-22Lehr Martin A.Buy52.68K$7.14376.14K
2021-10-22Dick Evan G.Buy26.59K——
2021-10-22Dick Evan G.Sell26.59K——
2021-10-22Levit Alex C.Buy3.00K$5.0015.00K
2021-10-22Lehr Martin A.Buy586.48K——
2021-10-22Lehr Martin A.Buy210.72K——
2021-10-22Lehr Martin A.Buy10.00K$5.0050.00K
2021-10-22Lehr Martin A.Buy52.68K$7.14376.14K
2021-10-22Lehr Martin A.Sell210.72K——
2021-10-22Lehr Martin A.Sell586.48K——
2021-10-22Dick Evan G.Buy26.59K——
2021-10-19Dick Evan G.Sell0——
2021-10-19Rencher William F.Sell416$20.528.54K
2021-10-19Lehr Martin A.Sell0——
2021-10-19Lehr Martin A.Sell281.35K$4.941.39M
2021-10-19Lehr Martin A.Other210.72K——
2021-10-19Lehr Martin A.Other586.48K——
2021-10-19Levit Alex C.Sell52.75K$4.94260.60K
2021-10-19Levit Alex C.Sell833$5.704.75K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 81, holders +19 vs prior quarter. Ownership 66.23%.

HolderSharesChangeChange %Value
NEXTECH INVEST LTD.7.42M00.00%4.11M
DEEP TRACK CAPITAL, LP7.42M00.00%4.11M
SOLEUS CAPITAL MANAGEMENT, L.P.7.06M100.00K+1.44%3.91M
BLACKROCK, INC.6.17M5.32M+628.63%3.42M
AVIDITY PARTNERS MANAGEMENT LP5.00M00.00%2.77M
FRANKLIN TEMPLETON INC3.80M00.00%2.11M
VANGUARD CAPITAL MANAGEMENT LLC3.43M99+0.00%1.90M
OCTAGON CAPITAL ADVISORS LP3.05M-2.20M-41.90%1.69M
BLUE OWL CAPITAL HOLDINGS LP2.93M-2.15M-42.35%1.63M
TCG CROSSOVER MANAGEMENT, LLC2.68M00.00%1.49M
GEODE CAPITAL MANAGEMENT, LLC1.83M1.23M+203.15%1.01M
STATE STREET CORP1.41M1.18M+505.30%782.90K
MPM BIOIMPACT LLC1.30M-9.38M-87.84%719.54K
RENAISSANCE TECHNOLOGIES LLC1.04M858.40K+469.07%576.83K
ACADIAN ASSET MANAGEMENT LLC1.01M1.01MNew559.00K
ADAR1 CAPITAL MANAGEMENT, LLC750.97K399.88K+113.89%415.96K
JANE STREET GROUP, LLC645.21K208.28K+47.67%357.38K
VANGUARD PORTFOLIO MANAGEMENT LLC638.88K638.88KNew353.94K
NORTHERN TRUST CORP615.58K512.32K+496.16%340.97K
VANGUARD FIDUCIARY TRUST CO433.89K92.54K+27.11%240.37K
MARSHALL WACE, LLP384.53K-2.56M-86.96%211.49K
XTX TOPCO LTD294.30K294.30KNew163.01K
QUBE RESEARCH & TECHNOLOGIES LTD257.07K245.67K+2155.38%142.39K
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.227.85K227.85KNew126.21K
CHARLES SCHWAB INVESTMENT MANAGEMENT INC227.85K227.85KNew126.21K

Earnings and financials

Context Therapeutics Inc. (CNTX) trades at $0.22, with a market cap of $20.29M and a trailing P/E of -0.50. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
0000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Context Therapeutics (CNTX) Financials: Revenue & Earnings

CNTX$0.22-0.01 -5.92%

$20.29M

Market Cap

-0.50

P/E

—

Forward P/E

—

Score

Price History